ArticleCancer chemotherapy and pharmacology2021
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors.
Haeseong Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it